OBLONG INC (OBLG)

US6744342048 - Common Stock

3.52  -0.16 (-4.35%)

After market: 3.84 +0.32 (+9.09%)

Fundamental Rating

2

Taking everything into account, OBLG scores 2 out of 10 in our fundamental rating. OBLG was compared to 279 industry peers in the Software industry. No worries on liquidiy or solvency for OBLG as it has an excellent financial health rating, but there are worries on the profitability. OBLG is valued expensive and it does not seem to be growing.



Quickly go to:

0

1. Profitability

1.1 Basic Checks

OBLG had negative earnings in the past year.
OBLG had a negative operating cash flow in the past year.
In the past 5 years OBLG always reported negative net income.
In the past 5 years OBLG always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of -225.11%, OBLG is doing worse than 97.48% of the companies in the same industry.
Looking at the Return On Equity, with a value of -288.82%, OBLG is doing worse than 84.17% of the companies in the same industry.
Industry RankSector Rank
ROA -225.11%
ROE -288.82%
ROIC N/A
ROA(3y)-166.17%
ROA(5y)-109.82%
ROE(3y)-249.25%
ROE(5y)-164.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Gross Margin value of 17.58%, OBLG is not doing good in the industry: 85.97% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of OBLG has declined.
The Profit Margin and Operating Margin are not available for OBLG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.07%
GM growth 5Y-9.55%

More info and screens

7

2. Health

2.1 Basic Checks

OBLG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OBLG has been increased compared to 1 year ago.
The number of shares outstanding for OBLG has been increased compared to 5 years ago.
There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

Based on the Altman-Z score of -53.12, we must say that OBLG is in the distress zone and has some risk of bankruptcy.
OBLG has a Altman-Z score of -53.12. This is amonst the worse of the industry: OBLG underperforms 97.84% of its industry peers.
There is no outstanding debt for OBLG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -53.12
ROIC/WACCN/A
WACC11.78%

2.3 Liquidity

OBLG has a Current Ratio of 4.53. This indicates that OBLG is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.53, OBLG belongs to the top of the industry, outperforming 85.25% of the companies in the same industry.
A Quick Ratio of 4.50 indicates that OBLG has no problem at all paying its short term obligations.
OBLG has a Quick ratio of 4.50. This is amongst the best in the industry. OBLG outperforms 85.25% of its industry peers.
Industry RankSector Rank
Current Ratio 4.53
Quick Ratio 4.5

More info and screens

0

3. Growth

3.1 Past

OBLG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -482.51%.
OBLG shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.84%.
The Revenue for OBLG have been decreasing by -21.23% on average. This is quite bad
EPS 1Y (TTM)-482.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3651.08%
Revenue 1Y (TTM)-35.84%
Revenue growth 3Y-37.13%
Revenue growth 5Y-21.23%
Sales Q2Q%-33.56%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OBLG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

OBLG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OBLONG INC

NASDAQ:OBLG (12/20/2024, 8:00:01 PM)

After market: 3.84 +0.32 (+9.09%)

3.52

-0.16 (-4.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2024-11-12
Earnings (Next)N/A N/A
Inst Owners2.49%
Inst Owner Change-83.74%
Ins Owners0.47%
Ins Owner Change0%
Market Cap4.01M
Analysts82.86
Price TargetN/A
Short Float %0.73%
Short Ratio0.17
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.45
P/FCF N/A
P/OCF N/A
P/B 0.86
P/tB 0.86
EV/EBITDA N/A
EPS(TTM)-13.16
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-2.83
FCFYN/A
OCF(TTM)-2.83
OCFYN/A
SpS2.42
BVpS4.1
TBVpS4.1
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -225.11%
ROE -288.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.58%
FCFM N/A
ROA(3y)-166.17%
ROA(5y)-109.82%
ROE(3y)-249.25%
ROE(5y)-164.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-23.07%
GM growth 5Y-9.55%
F-Score2
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.53
Quick Ratio 4.5
Altman-Z -53.12
F-Score2
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)0.78%
Cap/Depr(5y)1.48%
Cap/Sales(3y)0.28%
Cap/Sales(5y)0.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-482.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3651.08%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-35.84%
Revenue growth 3Y-37.13%
Revenue growth 5Y-21.23%
Sales Q2Q%-33.56%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.8%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y51.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.52%
OCF growth 3YN/A
OCF growth 5YN/A